Cargando…
A Nutritional Supplement as Adjuvant of Gabapentinoids for Adults with Neuropathic Pain following Spinal Cord Injury and Stroke: Preliminary Results
Gabapentinoids are first choice drugs for central neuropathic pain (CNP) despite limited evidence of efficacy and side effects affecting therapy outcomes. Nutraceuticals could improve their efficacy and tolerability. Our aim is to investigate the effect of NACVAN(®), in addition to gabapentinoids, o...
Autores principales: | Raffaeli, William, Felzani, Giorgio, Tenti, Michael, Greco, Luca, D’Eramo, Maria Pia, Proietti, Stefania, Morone, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531277/ https://www.ncbi.nlm.nih.gov/pubmed/37761760 http://dx.doi.org/10.3390/healthcare11182563 |
Ejemplares similares
-
Clinical efficacy and tolerability of Gabapentinoids with current prescription patterns in patients with Neuropathic pain
por: Shaheen, Abida, et al.
Publicado: (2019) -
Mirogabalin, a selective gabapentinoid for managing neuropathic pain—A curtain raiser
por: Nair, Abhijit
Publicado: (2022) -
The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids
por: Tang, Hui, et al.
Publicado: (2023) -
Mechanisms of the gabapentinoids and α
(2)
δ‐1 calcium channel subunit in neuropathic pain
por: Patel, Ryan, et al.
Publicado: (2016) -
Gabapentinoids Associated With Lower Explantation Rate in 203 Patients With Spinal Cord Stimulation for Failed Back Surgery Syndrome
por: Nissen, Mette, et al.
Publicado: (2021)